renal replacement therapy – Page 2 – Communicable Diseases Research

Characteristics and outcomes of sepsis patients with and without COVID-19

Research article

Published on 2022-06-012022-10-05
Journal: Journal of infection and public health
[Category] 바이오마커,

Heterologous immunization with BNT162b2 followed by mRNA-1273 in dialysis patients: seroconversion and presence of neutralizing antibodies

투석 환자에서 BNT162b2에 이어 mRNA-1273으로 이종 면역화: 혈청전환 및 중화항체 존재

Article

Published on 2022-05-252022-09-12
Journal: Nephrology, dialysis, transplantation : official p
[Category] COVID19(2023년), MERS, SARS, 진단,

[키워드] acute respiratory syndrome analysis anti-SARS-CoV-2 antibodies antibody BNT162b2 boost booster Cambridge Characteristics Concentration coronavirus COVID-19 cut-off dialysis disease dose Efficacy Elasomeran Elecsy Genscript Germany heterologous immunization high risk Humoral immunity immunoreactivity Immunosuppression Infection Mainz Moderna Mortality mRNA vaccine mRNA-1273 mRNA-1273 booster neutralization Neutralization assay Neutralizing antibodies neutralizing antibody of BNT162b2 Patient patients performed plaque reduction neutralization PRNT receiver receiving renal replacement therapy ROC Roche Diagnostics SARS-CoV-2 SARS-CoV-2 spike Seroconversion surrogate Test the SARS-CoV-2 titre Tozinameran USA vaccination vaccination. virus-neutralizing was measured was reduced were measured were used while wild-type SARS-CoV-2 York
[DOI] 10.1093/ndt/gfac018 PMC 바로가기 [Article Type] Article

Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19

Observational Study

Published on 2022-05-012022-10-05
Journal: Clinical and experimental nephrology
[Category] 임상,

[키워드] 95%CI Acute kidney injury Admission AKI Atherosclerosis center chronic Chronic kidney disease Chronic kidney disease. CKD comparable consecutive patient Control control group control patient controls coronavirus COVID-19 COVID-19 infection COVID-19 outbreak COVID-19 outcomes creatinine Diabetes Mellitus died disease severity evaluated event Evidence Hospitalization Hospitalized hypertension infected with COVID-19 information kidney Kidney disease Older outcome Pathogenesis Patient patients Prevalence renal renal replacement therapy required retrospective serum serum creatinine severity significantly more Stage while
[DOI] 10.1007/s10157-022-02180-6 PMC 바로가기 [Article Type] Observational Study

Comparison of clinical characteristics and outcomes of COVID-19 patients undergoing early versus late intubation from initial hospital admission: A systematic review and meta-analysis

Review article

Published on 2022-05-012022-10-05
Journal: Respiratory investigation
[Category] COVID19(2023년), SARS, 바이오마커, 임상,

[키워드] 95% confidence interval age Alter body mass index Clinical characteristics Clinical outcome Cochrane Library cohort study comparable coronavirus disease COVID-19 COVID-19 pandemic COVID-19 patient database defined delayed intubation determine diabetes Early intubation early phase explain First wave hospital Hospital admission hospital mortality rate IMV in-hospital mortality initial intubation Invasive mechanical ventilation Late intubation mechanical ventilation Meta-analysis mortality rate no significant difference Odds ratio Organ failure outcome pandemic Patient Primary outcome renal replacement therapy required Research Result RRT SARS-CoV-2 searched Sex significantly SOFA SOFA score systematic review Therapies Web of Science while
[DOI] 10.1016/j.resinv.2022.02.007 [Article Type] Review article

Organ dysfunction and death in patients admitted to hospital with COVID-19 in pandemic waves 1 to 3 in British Columbia, Ontario and Quebec, Canada: a cohort study

Observational Study

Published on 2022-04-192022-10-04
Journal: CMAJ open
[Category] COVID19(2023년), SARS, 임상,

[키워드] 28-day mortality 95% CI 95% confidence interval acute COVID-19 adjusted Admission angiotensin receptor blocker ARB association average baseline characteristics changes in cohort study Community Comorbidity conducted COVID-19 pandemic death demographic characteristics Dexamethasone dysfunction examined excluded hospital Hospital admission IMPROVE in-hospital mortality Invasive mechanical ventilation less Logistic lower mortality management Mortality multicentre Observational cohort study Odds ratio organ support outcome outcomes pandemic Patient Pragmatic readmission Regression model remained renal dysfunction renal replacement therapy RRT severity of illness significantly lower therapy Vasopressor with COVID-19
[DOI] 10.9778/cmajo.20210216 PMC 바로가기 [Article Type] Observational Study

The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial

입원한 COVID-19 환자(BeeCovid2)의 보조 치료제로 표준화된 브라질 녹색 프로폴리스 추출물(EPP-AF)의 사용: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약

Article

Published on 2022-04-042022-09-11
Journal: Trials
[Category] 임상,

[키워드] 1:1 2019 coronavirus disease ACE2 acute COVID-19 Acute kidney injury adjunct Administered adults hospitalized Affect affected age anti-inflammatory agents association Bacterial balloon pump Brazil Cancer patients chronic disease Chronic diseases Chronic kidney disease clinical study conducted coronavirus disease COVID-19 demonstrated diagnosis of COVID-19 double-blinded ECMO Effectiveness Evidence experimental evidence extracorporeal membrane oxygenation Fungal infection groups heart failure HIV patients Hospital stay hospitalized COVID-19 patient hospitalized patients immunoregulation Immunosuppression impacts impossibility include Infection intra-aortic balloon pump Kidney disease Liver disease mechanical ventilation medication moderate moderate to severe outcome PAK1 PAK1 blocker pandemic Patient patients hospitalized Placebo placebo-controlled clinical study pregnant women Primary outcome Propolis protocol randomization Randomized Randomized controlled trial receive reducing renal replacement therapy replacement therapy secondary Secondary infection Secondary outcomes severe liver disease Spread standard care Study protocol Symptom targets TMPRSS2 TMPRSS2. Treatment Trial vasoactive drugs with COVID-19
[DOI] 10.1186/s13063-022-06176-1 PMC 바로가기 [Article Type] Article

Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?

COVID-19 관련 급성 신장 손상의 조기 예측: 혈청 NGAL 및 혈청 시스타틴 C 수치가 혈청 크레아티닌보다 나은가요?

Article

Published on 2022-04-012022-09-11
Journal: Clinical biochemistry
[Category] COVID19(2023년), SARS, 바이오마커, 진단,

[키워드] acute kidney Acute kidney injury Admission AKI AUC Biomarker Biomarkers clinical settings comparable coronavirus coronavirus disease coronavirus disease-2019 COVID-19 COVID-19 patients creatinine cystatin C demonstrated Diagnosis diagnostic disease severity elevated emergency department etiologies high risk ICU ICU admission intensive care intensive care unit Intervention kidney Kidney injury Laboratory medicine laboratory-confirmed Laboratory-confirmed COVID-19 Mortality neutrophil predictor presenting Primary outcome renal replacement therapy replacement therapy risk stratification RRT SARS-CoV-2 SARS-CoV-2. secondary outcome Secondary outcomes sensitivity serum serum creatinine shown suggested utility while
[DOI] 10.1016/j.clinbiochem.2022.01.006 PMC 바로가기 [Article Type] Article

Echocardiographic predictors of mortality and morbidity in COVID-19 disease using focused cardiovascular ultrasound

Research article

Published on 2022-04-012022-10-05
Journal: IJC Heart & Vasculature
[Category] 바이오마커, 진단,

Differences between COVID-19-induced acute kidney injury and chronic kidney disease patients

COVID-19 유발 급성 신장 손상과 만성 신장 질환 환자의 차이점

Article

Published on 2022-04-012022-09-11
Journal: J Bras Nefrol
[Category] COVID19(2023년), SARS, 치료기술,

Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study

Research article

Published on 2022-03-012022-10-05
Journal: The American journal of medicine
[Category] 바이오마커, 유전자 메커니즘, 임상, 치료법,

[키워드] adjusted analyses African Americans biomarkers of inflammation black Black patient Black race both group C-reactive protein clinical trial clinical trials collected data consecutive patient contribute convalescent serum coronavirus coronavirus disease Corticosteroid Corticosteroids COVID-19 death described determine Diabetes Mellitus difference Disparities enrolled Enrollment higher odd Hospitalization Hospitalized hypertension In-hospital inflammatory markers Inflammatory response less M2C2 mechanical ventilation Mortality not significant obesity outcome patients patients hospitalized patients with COVID-19 prevalence of COVID-19 Prospective prospective cohort study Racial receive receptor Remdesivir renal replacement therapy Result risk factor SARS-CoV-2 Therapies
[DOI] 10.1016/j.amjmed.2021.10.026 [Article Type] Research article